These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 201222)
21. Cyclic AMP and inositol phosphate accumulations in rat brain cortical slices following chronic citalopram or desipramine administration. Sapena R; Morin D; Zini R; Tillement JP Drugs Exp Clin Res; 1994; 20(3):93-102. PubMed ID: 7956721 [TBL] [Abstract][Full Text] [Related]
22. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. Dibner MD; Molinoff PB J Pharmacol Exp Ther; 1979 Sep; 210(3):433-9. PubMed ID: 39161 [TBL] [Abstract][Full Text] [Related]
23. Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine. Fuller RW; Snoddy HD; Perry KW; Bymaster FP; Wong DT Biochem Pharmacol; 1978 Jan; 27(2):193-8. PubMed ID: 623674 [No Abstract] [Full Text] [Related]
24. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850 [TBL] [Abstract][Full Text] [Related]
25. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment. Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498 [TBL] [Abstract][Full Text] [Related]
26. Adaptive responses of brain cyclic AMP-generating systems to alterations in synaptic input. Dismukes RK; Daly JW J Cyclic Nucleotide Res; 1976; 2(5):321-36. PubMed ID: 12192 [TBL] [Abstract][Full Text] [Related]
27. Attenuation of ethanol intake by 5-hydroxytryptamine uptake blockade in laboratory rats: II. Possible interaction with brain norepinephrine. Rockman GE; Amit Z; Carr G; Ogren SO Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):260-5. PubMed ID: 526080 [TBL] [Abstract][Full Text] [Related]
28. Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine. Baron BM; Ogden AM; Siegel BW; Stegeman J; Ursillo RC; Dudley MW Eur J Pharmacol; 1988 Sep; 154(2):125-34. PubMed ID: 2465908 [TBL] [Abstract][Full Text] [Related]
29. Norepinephrine stimulated cyclic AMP accumulation in rat limbic forebrain slices: partial mediation by a subpopulation of receptors with neither alpha nor beta characteristics. Mobley PL; Sulser F Eur J Pharmacol; 1979 Dec; 60(2-3):221-7. PubMed ID: 230979 [TBL] [Abstract][Full Text] [Related]
30. Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain. Fuller RW; Perry KW Neuropharmacology; 1977; 16(7-8):495-7. PubMed ID: 917253 [No Abstract] [Full Text] [Related]
31. Neuronal uptake inhibitors, nisoxetine and fluoxetine on rat vascular contractions. Cohen ML; Wiley KS Eur J Pharmacol; 1977 Aug; 44(3):219-29. PubMed ID: 891602 [TBL] [Abstract][Full Text] [Related]
32. Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'-monophosphate systems in rat brain. Cohen RM; Ebstein RP; Daly JW; Murphy DL J Neurosci; 1982 Nov; 2(11):1588-95. PubMed ID: 6292376 [TBL] [Abstract][Full Text] [Related]
33. Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions. Bymaster FB; Perry KW; Fuller RW; Wong DT Life Sci; 1977 Jan; 20(2):275-80. PubMed ID: 839960 [No Abstract] [Full Text] [Related]
34. dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart. Wong DT; Horng JS; Bymaster FP Life Sci; 1975 Sep; 17(5):755-60. PubMed ID: 1207394 [No Abstract] [Full Text] [Related]
35. Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine. Nalepa I; Manier DH; Gillespie DD; Rossby SP; Schmidt DE; Sulser F Eur Neuropsychopharmacol; 1998 Aug; 8(3):227-32. PubMed ID: 9716317 [TBL] [Abstract][Full Text] [Related]
36. A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain. Vetulani J; Stawarz RJ; Dingell JV; Sulser F Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):109-14. PubMed ID: 183150 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic effects in man of a specific serotonin-reuptake inhibitor. Lemberger L; Rowe H; Carmichael R; Oldham S; Horng JS; Bymaster FP; Wong DT Science; 1978 Jan; 199(4327):436-7. PubMed ID: 619465 [TBL] [Abstract][Full Text] [Related]
38. Cyclic AMP response to norepinephrine in the limbic forebrain of male and female rats: effect of desipramine. Mishra R; Sulser F Biochem Pharmacol; 1981 Nov; 30(22):3126-8. PubMed ID: 6279104 [No Abstract] [Full Text] [Related]
39. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats. Fuller RW; Snoddy HD Pharmacol Biochem Behav; 1986 Feb; 24(2):281-4. PubMed ID: 3485293 [TBL] [Abstract][Full Text] [Related]
40. Effects of central and peripheral pretreatment with fluoxetine in gustatory conditioning. Lorden JF; Nunn WB Pharmacol Biochem Behav; 1982 Sep; 17(3):435-43. PubMed ID: 6292958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]